Key result
IKs inhibition exacerbates veratridine-induced QT prolongation and action potential duration.
Why the study?
The consequences of combined IKs current inhibition with an increase of the late sodium current (INaL) on cardiac repolarization had not been studied or reported in the literature.
p-value: p=<0.001
May potentiate QT prolongation with combined IKs/INaL modulators; hypothesis-generating for repolarization reserve and requires clinical validation.
The slow delayed rectifier K+ current (IKs) mediated by KCNQ1/KCNE1 channels contributes to the cardiac action potential in human and other species. Several studies have shown that IKs protects the heart from excessive action potential prolongation induced by the rapid delayed rectifier K+ current (IKr) inhibition. Moreover, several studies have shown that combined pharmacological inhibition of IKs and IKr currents increases cardiac parameters such as instability and dispersion of repolarization, and short term QT interval variability. It is known these effects promote a high risk of occurrence of « torsade de pointes ». However, the consequences of combined IKs current inhibition with an increase of the late sodium current (INaL) on cardiac repolarization has not been studied and reported in the literature. The aim of this work is to study the effects of pharmacological inhibition of IKs with chromanol 293B, a reference inhibitor of IKs current, during action potential prolongation promoted by INaL pharmacological activation by veratridine. These effects were also evaluated in the presence of doxorubicin, an anticancer drug increasing cardiac ventricular repolarisation and QT interval duration.MethodsInvolvement of IKs current in repolarization reserve process was studied in the presence of INaL current activated by veratridine on Guinea pig papillary muscle and isolated perfused heart using intracellular microelectrode and Langendorff techniques. Action potentials (AP) and Electrocardiogram (ECG) were recorded in the presence of veratridine alone and in the presence of veratridine and chromanol 293B or doxorubicin. The IKs current inhibition was previously evaluated on HEK-293/KCNQ1-KCNE1 stable cell line by chromanol 293B (supplemental Figure 1) and doxorubicin (Previous work).ResultsOur results show that the IKs current is inhibited by chromanol 293B, on the HEK-293/KCNQ1-KCNE1 stable cell line, with an IC50 = 6.51 μM, close to the results described in the literature for this compound. Our results show also a key role of IKs current on the repolarization reserve process. Indeed, an increase of cardiac parameters such as action potential duration and triangulation, and QT and Tpeak-Tend intervals is observed by IKs inhibition by chromanol 293B and doxorubicin in the presence of INaL current.
No takes yet. Share an insight, caveat, or question.
Printemps et al. (2019) studied Cardiac repolarization reserve (preclinical). Chromanol 293B and Doxorubicin (during INaL activation with Veratridine) vs. Veratridine alone was evaluated on QT interval duration change (p=<0.001). Pharmacological inhibition of the IKs current by chromanol 293B or doxorubicin significantly exacerbated action potential prolongation and QT interval increases induced by INaL activation with veratridine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: